GARP Research Maintains a 'Buy' on Conceptus (CPTS); Very Attractive Name in Health Care
Tweet Send to a FriendGet Alerts CPTS Hot Sheet
Price: $31.02 --0%
Rating Summary:
4 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 8 | New: 17
Rating Summary:
4 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 8 | New: 17
Trade CPTS Now!
GARP Research maintains a 'Buy' on Conceptus (NASDAQ: CPTS).
Analyst, Alastair Mackay, said, "Q1 revenue rose 9% on a rebound of domestic sales from 1Q11’s mid-recession low point, prompting an increase to guidance. Then Hologic (Nasdaq: HOLX) settled with Conceptus, agreeing to pull Adiana. This led to a second upwards adjustment. CPTS has leapt 36% since earnings were announced."
"We think CPTS is one of the most attractive names in health care. Hysteroscopic sterilization should continue to take share from tubal ligation, given the benefits of HS for patients, physicians, and payers."
For an analyst ratings summary and ratings history on Conceptus click here. For more ratings news on Conceptus click here.
Shares of Conceptus closed at $15.18 yesterday, with a 52 week range of $9.68-$15.72.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Alastair Mackay, said, "Q1 revenue rose 9% on a rebound of domestic sales from 1Q11’s mid-recession low point, prompting an increase to guidance. Then Hologic (Nasdaq: HOLX) settled with Conceptus, agreeing to pull Adiana. This led to a second upwards adjustment. CPTS has leapt 36% since earnings were announced."
"We think CPTS is one of the most attractive names in health care. Hysteroscopic sterilization should continue to take share from tubal ligation, given the benefits of HS for patients, physicians, and payers."
For an analyst ratings summary and ratings history on Conceptus click here. For more ratings news on Conceptus click here.
Shares of Conceptus closed at $15.18 yesterday, with a 52 week range of $9.68-$15.72.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Adobe (ADBE) Posts Positive Creative Cloud Subscriber Surprise in Q2 - Jefferies
- UPDATE: Macquarie Downgrades Sprint (S) to Neutral
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
